TrialPath
← Back to searchRecruiting

Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

NCT05610436 · Central Hospital, Nancy, France
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Post-Covid Condition Monitoring Cohort: Evaluation of the Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors
About this study
The aim of our cohort is to collect prospectively, in a standardized and exhaustive manner, the health data of patients referred to the CAPCoV, our holistic referal post covid clinics for post-covid condition in order to be able to identify typical profiles of patients suffering from post covid syndrome and to follow the evolution of their disease over time.
Eligibility criteria
Inclusion Criteria: * outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for post-Covid condition according to WHO definition Exclusion Criteria: * patient opposing the processing for research purposes of their data collected in routine care for their care
Study design
Enrollment target: 500 participants
Age groups: adult, older_adult
Timeline
Starts: 2022-01-07
Estimated completion: 2026-06
Last updated: 2022-11-09
Primary outcomes
  • Symptoms (every 6 months up to 3 years)
Sponsor
Central Hospital, Nancy, France · other
Contacts & investigators
ContactFrancois GOEHRINGER, MD · contact · francois.goehringer@chru-nancy.fr · +33383154097
InvestigatorFrancois GOEHRINGER, MD · principal_investigator, Infectious Diseases Department, Nancy University Hospital,F-54000 Nancy, France.
All locations (1)
Nancy University HospitalRecruiting
Vandœuvre-lès-Nancy, Grand Est, France
Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors · TrialPath